drugset / Trial / NCT01001520
Neural Substrates in Nicotine Withdrawal
Phase 2
Completed
218 enrolled
University of Pennsylvania
National Institute on Drug Abuse (NIDA) · collab
RandomizedCrossoverDouble-blindTreatment
Summary
This study will test the hypothesis that a medication called tolcapone (Brand Name: Tasmar) will help reduce cognitive problems that smokers experience when they quit. This study will also determine whether the benefits of this medication differ depending on a smokers' genetic background.
Timeline
- Start
- 2010-01
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tolcapone | Unknown | 200 mg | Oral |